Trademark applications and grants for Cara Therapeutics Inc. Cara Therapeutics Inc has 17 trademark applications. The latest application filed is for "OPRUITY"
Patent Application | Date |
---|---|
Oral Formulations of Kappa Opioid Receptor Agonists 20210346505 - 17/242678 WILSON; Bryan R. ;   et al. | 2021-11-11 |
OLIGOSACCHARIDE FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS 20210290723 - 17/204986 WILSON; Bryan R. ;   et al. | 2021-09-23 |
Oral Formulations of Kappa Opioid Receptor Agonists 20200085961 - 16/570333 WILSON; Bryan R. ;   et al. | 2020-03-19 |
SYNTHETIC PEPTIDE AMIDES 20190241610 - 16/199308 Schteingart; Claudio D. ;   et al. | 2019-08-08 |
SYNTHETIC PEPTIDE AMIDES AND DIMERS THEREOF 20190177365 - 16/029776 Schteingart; Claudio D. ;   et al. | 2019-06-13 |
NCAGE Code | 5LBL4 | CARA THERAPEUTICS INC. |
CAGE Code | 5LBL4 | CARA THERAPEUTICS INC. |
SEC | 0001346830 | Cara Therapeutics, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.